North America Lipid POCT Market to 2032
Overview
The North America Lipid POCT Market is expected to reach a 553.72 USD Million by 2032 and is projected to grow at a CAGR of 7.82% from 2025 to 2032.
Revenue, 2024 (USD Million)
377.62
Forecast, 2032 (USD Million)
553.72
CAGR, 2024 - 2032
7.82%
Report Coverage
North America
North America Lipid POCT Market 2018-2032 USD Million
North America Lipid POCT Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 377.62 USD Million
- Projected Market Size (2032): 553.72 USD Million
- CAGR (2025-2032): 7.82%
Key Findings of North America Lipid POCT Market
- The North America Lipid POCT Market was valued at 377.62 USD Million in 2024.
- The North America Lipid POCT Market is likely to grow at a CAGR of 7.82% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Testing in Mode Segment accounted for the largest share of the market with a revenue of 306.04 USD Million
- The fastest growing segment Alere Cholestech LDX in Brand Segment grew Fastest with a CAGR of 11.22% during the forecast period from 2024 to 2032.
North America Lipid POCT Market Scope
North America Lipid POCT Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tenders
End User
- Other End Users
- Research Laboratories
- Home Care
- Professional Diagnostic Centers
- Hospitals
Brand
- PTS Cardiochek
- Alere Afinion
- Alere Cholestech LDX
- Others
- Roche Cobas B 101
- Roche Reflotron
Platform
- Microfluidics
- Dipsticks
- Immunoassays
- Molecular Diagnostics
- Lateral Flow Assays /Immunochromatography Tests
Mode
- OTC-Based Testing
- Prescription-Based Testing
Application
- Others
- Tangier Disease
- Familial Hypercholesterolemia
- Hyperlipoproteinemia
- Hypertriglyceridemia
- Hyperlipidemia
Type
- Consumables And Kits
- Instruments
North America Lipid POCT Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 377.62 USD Million |
| Market Value in 2032 | 553.72 USD Million |
| CAGR (2025-2032) | 7.82% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Brand,Platform,Mode,Application,Type |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 377.62 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 343.49 USD Million in 2024.
Segments and Scope
-
North America Lipid POCT Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in North America Lipid POCT Market to 2032 with a revenue of 232.19 USD Million in the year 2024.
- Retail Sales is the Fastest growing segment in North America Lipid POCT Market to 2032 with a Growth rate of 7.48 % in forecast period 2025-2032.
-
North America Lipid POCT Market to 2032, By End User
- Hospitals is the largest segment in North America Lipid POCT Market to 2032 with a revenue of 127.47 USD Million in the year 2024.
- Professional Diagnostic Centers is the Fastest growing segment in North America Lipid POCT Market to 2032 with a Growth rate of 7.09 % in forecast period 2025-2032.
-
North America Lipid POCT Market to 2032, By Brand
- Roche Reflotron is the largest segment in North America Lipid POCT Market to 2032 with a revenue of 185.37 USD Million in the year 2024.
- Alere Cholestech LDX is the Fastest growing segment in North America Lipid POCT Market to 2032 with a Growth rate of 8.05 % in forecast period 2025-2032.
-
North America Lipid POCT Market to 2032, By Platform
- Molecular Diagnostics is the largest segment in North America Lipid POCT Market to 2032 with a revenue of 119.16 USD Million in the year 2024.
- Molecular Diagnostics is the Fastest growing segment in North America Lipid POCT Market to 2032 with a Growth rate of 8.75 % in forecast period 2025-2032.
-
North America Lipid POCT Market to 2032, By Mode
- Prescription-Based Testing is the largest segment in North America Lipid POCT Market to 2032 with a revenue of 306.04 USD Million in the year 2024.
- OTC-Based Testing is the Fastest growing segment in North America Lipid POCT Market to 2032 with a Growth rate of 7.42 % in forecast period 2025-2032.
-
North America Lipid POCT Market to 2032, By Application
- Hyperlipidemia is the largest segment in North America Lipid POCT Market to 2032 with a revenue of 232.28 USD Million in the year 2024.
- Hypertriglyceridemia is the Fastest growing segment in North America Lipid POCT Market to 2032 with a Growth rate of 7.05 % in forecast period 2025-2032.
-
North America Lipid POCT Market to 2032, By Type
- Instruments is the largest segment in North America Lipid POCT Market to 2032 with a revenue of 226.30 USD Million in the year 2024.
- Consumables And Kits is the Fastest growing segment in North America Lipid POCT Market to 2032 with a Growth rate of 6.89 % in forecast period 2025-2032.
North America Lipid POCT Market Company Share Analysis
| Company Name |
|
||
| Quest Diagnostics Incorporated | |||
| Abbott | |||
| A. Menarini Diagnostics s.r.l | |||
| F. Hoffmann-La Roche Ltd. | |||
| Siemens Healthcare GmbH | |||
North America Lipid POCT Market Geographical Sales Distribution, 2018-2032 USD Million
North America Lipid POCT Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Lipid POCT Market is segmented based on Segmentation Distribution Channel,End User,Brand,Platform,Mode,Application,Type.
North America Lipid POCT Market was valued at USD 377.62(Revenue in USD Million) in 2020.
North America Lipid POCT Market is projected to grow at a CAGR of 7.82% during the forecast period of 2024 to 2032.
The Prescription-Based Testing segment is expected to dominate the North America Lipid POCT Market, holding a largest market share of 306.04 USD Million in 2024
North America Lipid POCT Market Scope
North America Lipid POCT Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tenders
End User
- Other End Users
- Research Laboratories
- Home Care
- Professional Diagnostic Centers
- Hospitals
Brand
- PTS Cardiochek
- Alere Afinion
- Alere Cholestech LDX
- Others
- Roche Cobas B 101
- Roche Reflotron
Platform
- Microfluidics
- Dipsticks
- Immunoassays
- Molecular Diagnostics
- Lateral Flow Assays /Immunochromatography Tests
Mode
- OTC-Based Testing
- Prescription-Based Testing
Application
- Others
- Tangier Disease
- Familial Hypercholesterolemia
- Hyperlipoproteinemia
- Hypertriglyceridemia
- Hyperlipidemia
Type
- Consumables And Kits
- Instruments
Frequently Asked Questions
The North America Lipid POCT Market is segmented based on Segmentation Distribution Channel,End User,Brand,Platform,Mode,Application,Type.
North America Lipid POCT Market was valued at USD 377.62(Revenue in USD Million) in 2020.
North America Lipid POCT Market is projected to grow at a CAGR of 7.82% during the forecast period of 2024 to 2032.
The estimated market value of the North America Lipid POCT Market for final year is USD 553.72 (USD Million).
North America Lipid POCT Market Company Profiling
Frequently Asked Questions
The North America Lipid POCT Market is segmented based on Segmentation Distribution Channel,End User,Brand,Platform,Mode,Application,Type.
North America Lipid POCT Market was valued at USD 377.62(Revenue in USD Million) in 2020.
North America Lipid POCT Market is projected to grow at a CAGR of 7.82% during the forecast period of 2024 to 2032.
The estimated market value of the North America Lipid POCT Market for final year is USD 553.72 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.